VENICE (ITALPRESS) – “Experimentation, study, medicine and artificial intelligence, these are the watchwords of the second edition of the World Health Forum, our Olympics of research and health, which we inaugurated today in Padua. The Padua capital becomes, thanks to this event, an important cenacle for the development of all the issues that revolve around the scientific world and dear to the Veneto Region and on which 10.5 billion euros are invested every year. Artificial intelligence, which is already employed in Professor Dei Tos’s department of pathological anatomy, is one of the frontiers on which we will place maximum attention from here on, thanks to its innumerable medical applications, with the possibility of increasing by 20 percent the candidacy of patients for medical treatment. I thank the scientific committee for the choice of the 16 technical sessions that will animate these three days in Padua: the topics covered are not only the focuses of modern medicine, but are also assumptions that will guide our healthcare professionals in pursuing a better future.” With these words, the president of the Veneto Region, Luca Zaia, officially opened the second edition of World Health Forum Veneto 2025, which will continue until Saturday at the Padua Congress Center.
The event is sponsored by the Veneto Region, Padua Chamber of Commerce, Fondazione Cassa di Risparmio di Padova e Rovigo, the City of Padua and the University of Padua.
The second day, also at Padua Congress, opens tomorrow at 8:45 a.m. with greetings from Manuela Lanzarin, Health Councillor of the Veneto Region. At 9 a.m., we get into the swing of things with the keynote speech “Digital Pathology: combining archival histology, tissue imaging and spatial transcriptomics through machine learning” by Angelo Paolo Dei Tos, of the University of Padua, while with Stefano Gustincich, of the IIT Italian Institute of Technology in Genoa, we will delve into the topic related to “New RNAs from the dark side of the genome.”
Then space will be given to “Organoids and scaffolds: new 3D models for understanding human diseases” for the second session on Friday. With Paolo De Coppi, University College London Great Ormond Institute of Child Health, “Prenatal Diagnosis and Fetal Medicine” will be analyzed, and with Nicola Elvassore, from the Veneto Institute of Molecular Medicine, an in-depth look at “Engineering Brain Organoids as Disease Models.” Both meetings will be moderated by Stefano Piccolo.
For the third session of the second day, it will be the turn of “Metabolic Medicine: when the energy engine fails.” Reviewing the topic will be Paul Wuh-Liang Hwu, of the Center for Precision Medicine, China Medical University, Taiwan and California Institute for Gene Therapy, and Fatima Bosch, of the Center for Animal Biotechnology and Gene Therapy, Barcelona. At 11:45 a.m., Katherine High, CEO of RhyGaze, opens the fourth session, titled “Viruses: from enemies to allies in gene therapy.” This will be followed by Alessandro Aiuti, from the University “Vita-Salute” San Raffaele – San Raffaele Hospital in Milan, Italy, who will analyze lentivirus for hematopoietic stem cell gene therapy.
In the afternoon, however, molecular medicine will be discussed, and with the fifth session of the day, at 1:30 p.m., the topic of gene correction will be addressed with Franco Locatelli, of the Consiglio Superiore di Sanità – Ospedale Pediatrico Bambino Gesù in Rome and Paula Cannon, Keck School of Medicine, University of Southern in California, moderated by Alessandra Biffi of the University of Padua. The sixth session, at 2:25 p.m. on the topic of new drugs from pathogenic mutations, will feature speakers Danilo Norata, University of Milan, and Paolo Simioni, University of Padua, who will investigate new drugs from pathogenic mutations, moderated by Leonardo Salviati of the University of Padua.
At 3:20 p.m. it will be the turn of Mauro Giacca, of King’s College London and University of Trieste, and Marco Sandri, of the University of Padua, who during the seventh session will analyze the connection between heart and skeletal muscles: understanding and combating muscle loss. Paolo Simioni will moderate.
The focus of the eighth session, Friday at 4:15 p.m., will be on new technologies in surgery, and moderation will be by Claudio Zanon, of Motore Sanità, and Alfredo Guglielmi, of the University of Verona. They will be followed on stage by Pietro Ruggieri, Andrea Angelini and Franco Grego of the University of Padua, and by videoconference by Lumsden Alan B., DeBakey Heart & Vascular Center-Department of Cardiovascular Surgery – Houston Methodist Hospital, Pump & Pipes Conference.
The ninth and final session at 5:35 p.m. will be a panel discussion on precision medicine and investment in high-tech companies. Moderating the discussion will be Giorgio Palù and Rosario Rizzuto: speakers will be Lucia Aleotti, Menarini Group, Francesca Gennari, Therakos Italia, Nicoletta Luppi, MSD Italia, Gaudenzio Meneghesso, University of Padua, Msgr. Renzo Pegoraro, Pontifical Academy for Life, science journalist Chiara Sabelli and Fabio Turone, Center for Ethics in Science and Journalism (CESJ). Closing the second day of the Forum at 8:45 p.m. will be a concert by the OPV – Orchestra di Padova e del Veneto, which will perform Gustav Mahler’s Resurrection.
-Photo press office Veneto Region-.
(ITALPRESS).
